finasteride has been researched along with Urinary Retention in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (30.43) | 18.2507 |
| 2000's | 27 (58.70) | 29.6817 |
| 2010's | 5 (10.87) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaplan, SA | 2 |
| Caiwen, W; Changxiao, H; Shibing, Y; Zhengyong, Y | 1 |
| Bezemer, ID; Driessen, MT; Herings, RM; Kuiper, JG; Penning-van Beest, FJ; Roehrborn, CG; Vasylyev, A | 1 |
| Bell, CF; DerSarkissian, M; Duh, MS; Lefebvre, P; Swensen, AR; Xiao, Y | 1 |
| Davis, EA; Fenter, TC; Lin, PJ; Shah, MB | 1 |
| Hogue, SL; Naslund, M; Ong, C; Regan, TS | 1 |
| Bergner, D; Cook, TJ; Gray, T; Johnson-Levonas, AO; McConnell, JD; Narayan, P; Quezada, WA; Roehrborn, CG; Saltzman, B; Waldstreicher, J | 1 |
| Chung, BH; Hong, SJ; Kim, SI; Ko, WJ | 1 |
| O'Reilly, P | 1 |
| Djavan, B | 1 |
| Bruskewitz, R; Drisko, J; Gittelman, MC; Gottesman, JE; Malek, GH; McConnell, JD; Meehan, A; Nickel, JC; Roehrborn, CG; Saltzman, B; Suryawanshi, S; Waldstreicher, J | 1 |
| Bosch, RJ; Sturkenboom, MC; Verhamme, KM | 1 |
| Boyle, P; de la Rosette, J; Emberton, M; Harkaway, R; Logie, J; Roehrborn, C | 1 |
| Howe, RW; MacDonald, R; Wilt, TJ | 1 |
| Hargreave, TB; McNeill, AS | 1 |
| O'Leary, MP | 1 |
| Knottnerus, JA; Norg, RJ; Portegijs, PJ; van de Beek, K; van Schayck, CP | 1 |
| Grogg, AL; Issa, MM; Runken, MC; Shah, MB | 1 |
| Feliciano, AE; Hennenfent, BR; Lazarte, AR | 1 |
| Barry, MJ; Kaufman, DS; Wu, CL | 1 |
| Bensadoun, H | 1 |
| Andersen, JT; Boyle, P; Marshall, VR; Nickel, JC; Schulman, CC | 1 |
| Albertsen, P; Andriole, G; Bruskewitz, R; Holtgrewe, HL; Lieber, M; McConnell, JD; Nickel, JC; Roehrborn, CG; Taylor, AM; Waldstreicher, J; Walsh, P; Wang, DZ | 1 |
| Wasson, JH | 1 |
| Nickel, JC | 1 |
| Kuo, HC | 1 |
| Marberger, MJ | 1 |
| Boyle, P | 1 |
| Casey, CM; Johnson, KH | 1 |
| Magoha, GA | 1 |
| Bonastre, J; Le Pen, C; Lukacs, B; Rumeau-Pichon, C | 1 |
| Kirby, R | 1 |
| Castellanos, R; Coffield, S; Cook, TJ; Geller, J; Kaplan, S; Lieber, M; Malek, GH; McConnell, JD; Resnick, M; Roehrborn, CG; Saltzman, B; Waldstreicher, J | 1 |
| Isotalo, T; Talja, M; Tammela, TL; Törmälä, P; Välimaa, T | 1 |
| Anderson, R; Brown, BT; Bruskewitz, R; Cox, C; Glickman, S; Herlihy, R; Holtgrewe, HL; Kandzari, S; Kornitzer, G; Nickel, GC; Roehrborn, CG; Taylor, A; Waldstreicher, J; Wang, D | 1 |
| Garvin, D; Gilhooly, P; Kaplan, S; Koppel, M; Labasky, R; Lee, M; Milsten, R; Pappas, F; Reddy, P; Rosenberg, S; Sussman, D; Waldstreicher, J; White, C | 1 |
| Andersen, JT; Gabriel, M; Malice, MP; Marberger, MJ; Meehan, A; Nickel, JC; Pappas, F; Stoner, E; Waldstreicher, J | 1 |
| Hellström, P; Isotalo, T; Perttilä, I; Talja, M; Tammela, TL; Törmälä, P; Välimaa, T | 1 |
| Scarpa, RM | 1 |
| Speakman, MJ | 1 |
| Howe, W; MacDonald, R; Wilt, TJ | 1 |
| Roehrborn, CG | 1 |
| Bryan, J; Christmas, TJ; Eardley, I; Holmes, SA; Kirby, RS; Liu, S; Shanmuganathan, K; Vale, JA; Webb, JA | 1 |
9 review(s) available for finasteride and Urinary Retention
| Article | Year |
|---|---|
Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of life.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combination; Finasteride; Humans; Male; Phytotherapy; Prostatic Hyperplasia; Quality of Life; Serenoa; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Urinary Bladder Neck Obstruction; Urinary Incontinence; Urinary Retention | 2003 |
Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects.
Topics: Adrenergic alpha-Antagonists; Aged; Cross-Over Studies; Doxazosin; Drug Combinations; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Treatment Outcome; Urinary Retention | 2004 |
Acute urinary retention in men: the risks and outcomes with medical therapy.
Topics: 5-alpha Reductase Inhibitors; Acute Disease; Enzyme Inhibitors; Finasteride; Humans; Male; Risk Factors; Urinary Catheterization; Urinary Retention | 2005 |
[Medical treatment of benign hypertrophy of the prostate].
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Plant Extracts; Prostatic Hyperplasia; Ultrasonography; Urinary Retention | 1995 |
Some remarks on the epidemiology of acute urinary retention.
Topics: Acute Disease; Adult; Age Distribution; Aged; Alcohol Drinking; Anesthetics, General; Cohort Studies; Enzyme Inhibitors; Finasteride; Humans; Incidence; Male; Middle Aged; Prevalence; Prostatic Hyperplasia; Risk Factors; Urinary Retention; Urodynamics | 1998 |
[Medical-economic models of benign prostatic hypertrophy].
Topics: Acute Disease; Age Factors; Aged; Aged, 80 and over; Clinical Trials as Topic; Costs and Cost Analysis; Endoscopy; Enzyme Inhibitors; Finasteride; Humans; Life Expectancy; Male; Markov Chains; Middle Aged; Models, Theoretical; Monte Carlo Method; Placebos; Probability; Prostatectomy; Prostatic Hyperplasia; Urinary Retention | 1998 |
Initial choices and final outcomes in lower urinary tract symptoms.
Topics: Adrenergic alpha-Antagonists; Finasteride; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome; Urinary Retention | 2001 |
Terazosin for treating symptomatic benign prostatic obstruction: a systematic review of efficacy and adverse effects.
Topics: Adrenergic alpha-Antagonists; Aged; Drug Combinations; Enzyme Inhibitors; Finasteride; Humans; Male; Patient Dropouts; Prostatic Hyperplasia; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Urinary Retention; Urination | 2002 |
Reporting of acute urinary retention in BPH treatment trials: importance of patient follow-up after discontinuation and case definitions.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Enzyme Inhibitors; Finasteride; Follow-Up Studies; Humans; Incidence; Male; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Urinary Retention | 2002 |
15 trial(s) available for finasteride and Urinary Retention
| Article | Year |
|---|---|
Randomized controlled trial on the efficacy of bladder training before removing the indwelling urinary catheter in patients with acute urinary retention associated with benign prostatic hyperplasia.
Topics: Aged; Aged, 80 and over; Catheters, Indwelling; Combined Modality Therapy; Device Removal; Drug Therapy, Combination; Finasteride; Humans; Male; Middle Aged; Muscle Tonus; Muscle, Smooth; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder; Urinary Catheterization; Urinary Retention; Urological Agents | 2014 |
Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes.
Topics: Acute Disease; Adult; Area Under Curve; Disease Progression; Enzyme Inhibitors; Finasteride; Humans; Male; Predictive Value of Tests; Prostate-Specific Antigen; Prostatectomy; Prostatic Hyperplasia; ROC Curve; Surveys and Questionnaires; Treatment Outcome; Urinary Bladder Neck Obstruction; Urinary Retention | 2002 |
Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia.
Topics: Acute Disease; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Incidence; Male; Middle Aged; Prostatic Hyperplasia; Urinary Retention | 2004 |
The effectiveness of a treatment protocol for male lower urinary tract symptoms in general practice: a practical randomised controlled trial.
Topics: Aged; Clinical Protocols; Cohort Studies; Enzyme Inhibitors; Family Practice; Finasteride; Humans; Male; Middle Aged; Netherlands; Practice Guidelines as Topic; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention; Urinary Tract Infections | 2006 |
Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia.
Topics: Acute Disease; Aged; Aged, 80 and over; Enzyme Inhibitors; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Surgical Procedures, Operative; Urinary Retention | 1997 |
The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.
Topics: 5-alpha Reductase Inhibitors; Aged; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Incidence; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Urinary Retention; Urination | 1998 |
Placebo therapy of benign prostatic hyperplasia: a 25-month study. Canadian PROSPECT Study Group.
Topics: Aged; Aged, 80 and over; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Placebo Effect; Placebos; Prostatic Hyperplasia; Treatment Outcome; Urinary Retention; Urination | 1998 |
Comparative study of therapeutic effect of dibenyline, finasteride, and combination drugs for symptomatic benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Follow-Up Studies; Humans; Male; Phenoxybenzamine; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Recurrence; Treatment Outcome; Urinary Retention; Urodynamics | 1998 |
Long-term effects of finasteride in patients with benign prostatic hyperplasia: a double-blind, placebo-controlled, multicenter study. PROWESS Study Group.
Topics: 5-alpha Reductase Inhibitors; Aged; Analysis of Variance; Double-Blind Method; Enzyme Inhibitors; Finasteride; Follow-Up Studies; Humans; Linear Models; Longitudinal Studies; Male; Middle Aged; Placebos; Proportional Hazards Models; Prostate; Prostatic Hyperplasia; Urinary Retention; Urination | 1998 |
Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group.
Topics: Acute Disease; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Hyperplasia; Urinary Retention | 1999 |
Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS Study Group.
Topics: Finasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Time Factors; Urinary Retention | 2000 |
Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride. The Pless Study Group.
Topics: Aged; Double-Blind Method; Finasteride; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Treatment Outcome; Urinary Retention | 2000 |
Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Combined experience from three large multinational placebo-controlled trials.
Topics: Acute Disease; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Male; Predictive Value of Tests; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Urinary Retention | 2000 |
A double-blind, randomized, placebo-controlled pilot study to investigate the effects of finasteride combined with a biodegradable self-reinforced poly L-lactic acid spiral stent in patients with urinary retention caused by bladder outlet obstruction from
Topics: Absorbable Implants; Aged; Aged, 80 and over; Combined Modality Therapy; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Lactic Acid; Male; Middle Aged; Pilot Projects; Polyesters; Polymers; Prostatic Hyperplasia; Stents; Treatment Outcome; Urinary Bladder Neck Obstruction; Urinary Retention | 2001 |
Finasteride in the treatment of benign prostatic hyperplasia. A urodynamic evaluation.
Topics: Aged; Aged, 80 and over; Androstenes; Azasteroids; Double-Blind Method; Finasteride; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Testosterone; Urinary Retention; Urination; Urodynamics | 1992 |
22 other study(ies) available for finasteride and Urinary Retention
| Article | Year |
|---|---|
Re: Rates of Prostate Surgery and Acute Urinary Retention for Benign Prostatic Hyperplasia in Men Treated with Dutasteride or Finasteride.
Topics: 5-alpha Reductase Inhibitors; Azasteroids; Dutasteride; Finasteride; Humans; Male; Prostatic Hyperplasia; Urinary Retention | 2017 |
Re: Analysis of Risk Factors Leading to Postoperative Urethral Stricture and Bladder Neck Contracture following Transurethral Resection of Prostate.
Topics: Contracture; Dutasteride; Finasteride; Humans; Male; Postoperative Complications; Prostatic Hyperplasia; Risk Factors; Transurethral Resection of Prostate; Urethral Stricture; Urinary Bladder Neck Obstruction; Urinary Retention | 2017 |
Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride.
Topics: 5-alpha Reductase Inhibitors; Acute Disease; Aged; Aged, 80 and over; Dutasteride; Finasteride; Humans; Incidence; Male; Middle Aged; Prostatectomy; Prostatic Hyperplasia; Urinary Retention | 2016 |
Comparing Clinical and Economic Outcomes Associated with Early Initiation of Combination Therapy of an Alpha Blocker and Dutasteride or Finasteride in Men with Benign Prostatic Hyperplasia in the United States.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cohort Studies; Disease Progression; Dutasteride; Finasteride; Health Care Costs; Humans; Longitudinal Studies; Male; Middle Aged; Prostatic Hyperplasia; Retrospective Studies; Treatment Outcome; United States; Urinary Retention | 2016 |
Dutasteride vs finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged > or =65 years.
Topics: 5-alpha Reductase Inhibitors; Acute Disease; Aged; Aged, 80 and over; Azasteroids; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatectomy; Prostatic Hyperplasia; Retrospective Studies; United States; Urinary Retention | 2008 |
5-Alpha reductase inhibitors in men with an enlarged prostate: an evaluation of outcomes and therapeutic alternatives.
Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Azasteroids; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Medicare; Prostatic Hyperplasia; Treatment Outcome; United States; Urinary Retention | 2008 |
When you just can't go: my patient, a 63-year old stockbroker, recalled his experience with acute urinary retention.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Hyperplasia; Urinary Retention | 2009 |
Identification of baseline clinical factors which predict medical treatment failure of benign prostatic hyperplasia: an observational cohort study.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Biopsy, Needle; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prostatic Hyperplasia; Risk Assessment; Severity of Illness Index; Treatment Failure; Urinary Retention; Urodynamics | 2003 |
Pharmaceutical review.
Topics: Adrenergic alpha-Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Neoplasms; Risk Assessment; Urinary Retention | 2003 |
Finasteride in benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Acute Disease; Adrenergic alpha-Antagonists; Cohort Studies; Doxazosin; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Hyperplasia; Retrospective Studies; Urinary Retention | 2004 |
5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery.
Topics: 5-alpha Reductase Inhibitors; Acute Disease; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Enzyme Inhibitors; Finasteride; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Prostatic Hyperplasia; Regression Analysis; Retrospective Studies; Urinary Retention | 2004 |
By the way, doctor. I developed acute urinary retention after having a pacemaker put in. I'm a 90-year-old man and in pretty good shape considering my age, but I'd rather not have any more procedures. What are my options?
Topics: Aged, 80 and over; Azasteroids; Dutasteride; Finasteride; Humans; Male; Pacemaker, Artificial; Postoperative Complications; Transurethral Resection of Prostate; Urinary Retention | 2006 |
A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasteride.
Topics: Acute Disease; Age Distribution; Aged; Azasteroids; Dutasteride; Finasteride; Follow-Up Studies; Humans; Incidence; Male; Managed Care Programs; Middle Aged; Multivariate Analysis; Probability; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome; Urinary Retention; Urodynamics | 2007 |
Repetitive prostatic massage and drug therapy as an alternative to transurethral resection of the prostate.
Topics: Adrenergic alpha-Antagonists; Aged; Anti-Infective Agents; Complementary Therapies; Finasteride; Humans; Male; Massage; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatitis; Retrospective Studies; Transurethral Resection of Prostate; Urinary Catheterization; Urinary Retention | 2006 |
Finasteride: new indication. Benign prostatic hypertrophy: sexual disorders.
Topics: Enzyme Inhibitors; Finasteride; France; Humans; Male; Prostatic Hyperplasia; Sexual Behavior; Urinary Retention | 2007 |
Case records of the Massachusetts General Hospital. Case 15-2008. A 55-year-old man with an elevated prostate-specific antigen level and early-stage prostate cancer.
Topics: 5-alpha Reductase Inhibitors; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Urinary Retention | 2008 |
Finasteride to prevent morbidity from benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Hyperplasia; Quality of Life; Risk Assessment; Urinary Retention | 1998 |
Finasteride for BPH.
Topics: Acute Disease; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Reproducibility of Results; Urinary Retention | 1998 |
Finasteride in the treatment of patients with moderate symptoms of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Disease Progression; Finasteride; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Urinary Retention; Urodynamics | 1998 |
Benign prostatic hyperplasia.
Topics: Acute Disease; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Hyperplasia; Risk Factors; Urinary Retention | 1999 |
A pilot study of a bioabsorbable self-reinforced poly L-lactic acid urethral stent combined with finasteride in the treatment of acute urinary retention from benign prostatic enlargement.
Topics: Acute Disease; Aged; Aged, 80 and over; Ambulatory Care; Combined Modality Therapy; Enzyme Inhibitors; Finasteride; Humans; Lactic Acid; Male; Middle Aged; Pilot Projects; Polyesters; Polymers; Prostatic Hyperplasia; Stents; Urinary Retention; Urination | 2000 |
Lower urinary tract symptoms: what are the implications for the patients?
Topics: Adrenergic alpha-Antagonists; Data Collection; Europe; Finasteride; Humans; Life Style; Male; Patient Acceptance of Health Care; Penile Erection; Prevalence; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Urinary Retention | 2001 |